Inhibition of oral shedding of herpes simplex virus by cytosine arabinoside.
D000818:Animals; D002460:Cell Line; D002648:Child; D003168:Complement Fixation Tests; D003561:Cytarabine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005891:Gingivitis / Q000150:complications / Q000188:drug therapy*; D006041:Goats / Q000276:immunology; D006561:Herpes Simplex / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007106:Immune Sera; D007070:Immunoglobulin A; D007275:Injections, Intravenous; D007668:Kidney / Q000196:embryology; D007945:Leukemia, Lymphoid / Q000150:complications; D012463:Saliva / Q000276:immunology; D018139:Simplexvirus / Q000187:drug effects*; D013280:Stomatitis / Q000150:complications / Q000188:drug therapy*; D010948:Viral Plaque Assay; D014779:Virus Replication / Q000187:drug effects*
D007106:Immune Sera; D007070:Immunoglobulin A; D003561:Cytarabine